Progyny, Inc. Share Price

Equities

PGNY

US74340E1038

Managed Healthcare

Real-time Estimate Cboe BZX 20:45:12 22/04/2024 BST 5-day change 1st Jan Change
33.06 USD +1.12% Intraday chart for Progyny, Inc. -2.13% -11.00%
Sales 2024 * 1.3B 105B Sales 2025 * 1.57B 127B Capitalization 3.14B 255B
Net income 2024 * 70M 5.67B Net income 2025 * 105M 8.51B EV / Sales 2024 * 2.22 x
Net cash position 2024 * 263M 21.31B Net cash position 2025 * 481M 39B EV / Sales 2025 * 1.7 x
P/E ratio 2024 *
47.9 x
P/E ratio 2025 *
32.3 x
Employees 565
Yield 2024 *
-
Yield 2025 *
-
Free-Float 91.14%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.90%
1 week-2.69%
Current month-13.76%
1 month-11.65%
3 months-13.53%
6 months+3.65%
Current year-11.51%
More quotes
1 week
31.80
Extreme 31.8
33.85
1 month
31.80
Extreme 31.8
38.98
Current year
31.80
Extreme 31.8
42.08
1 year
29.44
Extreme 29.44
44.95
3 years
25.67
Extreme 25.67
68.32
5 years
13.29
Extreme 13.29
68.32
10 years
13.29
Extreme 13.29
68.32
More quotes
Managers TitleAgeSince
Chief Executive Officer 56 31/12/16
President 47 28/02/21
Director of Finance/CFO 58 30/04/19
Members of the board TitleAgeSince
Director/Board Member 67 30/04/10
Director/Board Member 61 30/09/19
Director/Board Member 75 15/12/16
More insiders
Date Price Change Volume
22/04/24 33.1 +1.22% 467 841
19/04/24 32.7 +2.57% 1,132,212
18/04/24 31.88 -2.66% 1,295,915
17/04/24 32.75 -1.92% 637,578
16/04/24 33.39 -1.24% 629,842

Delayed Quote Nasdaq, April 22, 2024 at 05:04 pm

More quotes
Progyny, Inc. is a benefit management company. The Company specializes in fertility and family building benefits solutions in the United States. The Company’s clients include various employers across an array of industries. It has contracts to provide coverage to approximately 6.4 million employees and their partners (known as members). The Company provides its benefits through its proprietary Smart Cycle approach. Smart Cycles include the medical services required for a member’s full course of treatment, including all necessary diagnostic testing and access to the technology. In addition to its fertility benefits solution, the Company offers an integrated pharmacy benefits solution, Progyny Rx, which can be added by its clients. Progyny Rx provides its members with access to the medications needed during their fertility treatment. It provides care management services, as well as medication administration training, pharmacy support services and continuing patient care advocate support.
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
10
Last Close Price
32.7 USD
Average target price
46.9 USD
Spread / Average Target
+43.43%
Consensus